Background-Connection between the course of microvascular and infarct remodeling processes over time after reperfused ST-elevation acute myocardial infarction has not been fully elucidated. The aim of this study is to investigate the association of temporal changes in hemodynamics of microcirculation in the infarcted territory and infarct size (IS) after primary percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction. Methods and Results-Thirty-five patients admitted with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention were enrolled in the study. Coronary flow reserve (CFR), index of microvascular resistance (IMR), and IS were assessed 2 days after primary percutaneous coronary intervention and at the 5-month follow-up. The predictors of the 5-month IS were the baseline values of IS (␤ϭ0.6, PϽ0.001), IMR (␤ϭ0.280, Pϭ0.013), and CFR (␤ϭϪ0.276, Pϭ0.017). There were significant correlations between relative change in IS and relative change in measures of microvascular function (IS and CFR [rϭϪ0.51, Pϭ0.002]); IS and IMR ([rϭ0.55, Pϭ0.001]). In multivariate model, relative changes in IMR (␤ϭ0.552, Pϭ0.001) and CFR (␤ϭϪ0.511, Pϭ0.002) were the only predictors of relative change in IS. In patients with an improvement in IMR Ͼ33%, the mean IS decreased from 32.3Ϯ16.9% to 19.3Ϯ14% (Pϭ0.001) in the follow-up. Similarly, in patients with an improvement in CFR Ͼ41%, the mean IS significantly decreased from 29.9Ϯ20% to 15.8Ϯ12.4% (Pϭ0.003)
E picardial coronary artery occlusion is accompanied by microvascular damage during the course of ST-elevation acute myocardial infarction (STEMI). Excessive microvascular destruction is associated with greater infarct size (IS), worse myocardial function, and poor clinical outcome after STEMI. [1] [2] [3] [4] [5] In the models of reperfused acute myocardial infarction (AMI), it has been demonstrated that there is a causal connection between the amount of microvascular destruction and myocardial damage. 6 This proven concordance implies that therapeutic approaches should focus on preventing microvascular damage at acute phase of STEMI and stimulating reconstitution of microcirculation during follow-up to improve long-term myocardial healing and survival. Accordingly, our group recently reported that in patients with STEMI undergoing primary percutaneous coronary intervention (pPCI), (1) adjunctive intracoronary streptokinase administration immediately after primary pPCI im-proved microvascular function at early phase, 7 and (2) this improvement was associated with long-term preservation of left ventricular function and recovery in IS. 8 Additionally, in other studies, reflection of restoration of microvascular function in the infarct vessel territory has been hemodynamically evidenced by increase in coronary flow reserve (CFR) and decrease in microvascular resistance over the time after STEMI. 9, 10 However, the link between the temporal changes in microvascular function and infarct remodeling at long-term after STEMI has not been fully elucidated.
Clinical Perspective on p 215
We hypothesized that improvement in microvascular function over time after reperfused STEMI is related to the infarct healing process. This study examines the association of temporal changes in hemodynamics of microcirculation in the infarcted territory and in IS, which were simultaneously assessed in the subacute phase and at long-term follow-up in patients who were successfully treated with pPCI for STEMI.
Methods

Patient Population
Fifty-two patients admitted to our hospital with first STEMI were enrolled in the study. Diagnosis was based on the ongoing chest pain, ST segment elevation on ECG, and demonstration of occluded coronary artery at angiography. All patients underwent pPCI with bare-metal stent implantation within 12 hours (mean, 210Ϯ145 minutes.) of onset of symptoms resulting in Thrombolysis in Myocardial Infarction flow grade 3. Major exclusion criteria were culprit lesion in a saphenous vein graft, history of myocardial infarction, and contraindications to tirofiban, aspirin, clopidogrel, heparin, or singlephoton emission computed tomography (SPECT) imaging. Written informed consent was obtained from all patients. The study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by our hospital ethics committee.
Evaluation of Microvascular Function
The patients underwent coronary angiography and microvascular function assessment at 2 days (50Ϯ14 hours, nϭ52) and 5 months (20Ϯ2 weeks, nϭ43) after the acute event. For assessment of microvascular function, a pressure-temperature sensor-tipped guide wire (Pressure wire sensor 5, Radi Medical Systems, Uppsala, Sweden) was positioned distal to the stented segment of the infarct-related artery (IRA). Papaverine was given at doses of 20 mg intracoronary bolus for the left and 15 mg for the right coronary artery to induce hyperemia and repeated if necessary. The mean transit time at rest (Tmn r ) and during hyperemia (Tmn h ) was recorded after rapid injection of 3 mL of room temperature saline through the guiding catheter as described previously. 11 Tmn r and Tmn h were measured at least 3 times and were accepted when the variability between the 3 values obtained for Tmn r and Tmn h from the 3 measurements were Ͻ20%. Then, averaged values for Tmn r and Tmn h were calculated. The thermodilution-derived CFR was calculated as the Tmn r divided by the Tmn h . The index of microvascular resistance (IMR) was defined as the simultaneously measured distal coronary pressure multiplied by the Tmn h (mm Hgϫs or units [U]). 12
SPECT Protocol
Resting technetium-99m sestamibi SPECT studies were performed 4Ϯ1.5 days after pPCI (nϭ52) and at fifth month (20Ϯ2 weeks) in follow-up (nϭ43). All patients received an intravenous injection of 740 MBq of technetium-99m sestamibi; SPECT acquisitions were performed with a double-head camera system (Vertex plus ADAC/ Philips, Eindhoven, The Netherlands) equipped with low-energy parallel hole collimators 30 minutes after tracer application. SPECT images were analyzed by Bull's eye quantitative program to evaluate the IS alterations between the baselines and follow-up studies. Each polar map was normalized to its own maximal value. The size of defect was calculated with the use of a threshold of 60% as derived from phantom studies and was quantified as percentage of left ventricle.
Echocardiographic Analysis
Left ventricular end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV), and left ventricular ejection fraction (LVEF, area-length method) were measured by echocardiography at 4 days and at 5 months. Relative changes in LVESV, LVEDV, and LVEF between 4 days and 5 months were calculated in 35 patients who had both of the 2 microvascular evaluations and no restenosis at the 5-month angiography.
Statistical Analysis
Statistical tests were performed with Statistical Package for the Social Sciences program. All data were expressed as ϮSD. Temporal changes in IMR, CFR, and IS from baseline to 5-month follow-up were compared by using paired sample t test. Univariate linear regression analysis was used to evaluate the relationship between relative changes in measures of microvascular function (CFR and IMR) from baseline to long-term follow-up and IS. Multivariate linear regression analysis was applied to identify the independent predictors of relative change in IS including baseline IS, pain-to balloon time, blood pressure, blood glucose level at admission, and change in measures of microvascular function into the model. Univariate and multivariate linear regression analyses also were used to investigate the relationship between baseline indices of microvascular function and 5-month IS, including baseline IS, pain-to balloon time, blood pressure, blood glucose level at admission, and baseline microvascular perfusion parameters into the multivariate model as well. Partial correlation analysis with controlling of early-phase IS (fourth day) also was performed to examine the independent relations between baseline microvascular perfusion parameters and long-term IS (fifth month) and relative change in IS and relative change in microvascular perfusion parameters. Then, the 2 groups were identified according to mean value of relative change in CFR and IMR, in whom percent change in improvement in CFR or IMR from baseline to 5-month follow-up was below the mean and in whom percent change in improvement in CFR or IMR from baseline to 5-month follow-up was above the mean. Comparison of the mean value of relative changes in IS, left ventricular volumes, and ejection fraction from baseline to the 5-month follow-up between the 2 groups was performed by using independent t test. Categorical variables were compared by the 2 test. Significance was accepted at PϽ0.05.
Results
During follow-up, 1 patient died, 8 patients refused to come for second catheterization and SPECT imaging. Forty-three patients underwent follow-up SPECT imaging, coronary angiography, and intracoronary hemodynamic measurements at 5 months. Significant in-stent restenosis was detected in 8 patients at the 5-month angiography, and they did not undergo second intracoronary hemodynamic measurement and echocardiographic evaluation. Therefore, final study population consisted of 35 patients who had both of the first and second SPECT imaging, measures of microvascular function, and echocardiographic evaluations. The baseline clinical, angiographic, and hemodynamic characteristics were summarized in Table 1 . There was no significant difference in baseline characteristics between the patient groups, which were constituted on the basis of the improvement level (below or above mean) in coronary hemodynamics and IS. None of the patients had clinical evidence of reinfarction and repetitive myocardial ischemia during long-term follow-up. Correlation between early-phase microvascular function and late-term (fifth month) IS was analyzed in 43 patients who had early post-AMI microvascular evaluation and early post-AMI and late-term IS measurements.
The mean IS was 30.3Ϯ17.8% at baseline and 20.3Ϯ12.5% at 5-month follow-up (PϽ0.001). The mean IS decreased by 33% at 5 months with an absolute decrease (⌬IS) of 10Ϯ11.3%. Decrease in IS occurred to similar extent in small and large infarctions (rϭ0.82; PϽ0.001; Figure 1 ). All of the patients were hemodynamically stable at the initial period and at 5-month intracoronary hemodynamic measurements. The mean heart rates (min/s) were 75.2Ϯ7.7 at baseline and 77.4Ϯ8.9 at 5 months. The mean blood pressures were 94Ϯ14 mm Hg at baseline and 90.8Ϯ14 mm Hg at 5 months. At baseline (2 days) intracoronary hemodynamic measurements, the variability of Tmn within each set of 3 consecutive measurements was 12.5Ϯ8.8% at rest and 9.1Ϯ6.9% at hyperemia. At 5 months, the variability of Tmn within each set of 3 consecutive measurements was 11.3Ϯ8.2% at rest and 8.4Ϯ6.2% at hyperemia. These values are in accordance with earlier studies on coronary thermodilution. 13, 14 Baseline CFR at early post-AMI phase was 2.2Ϯ0.9 and it increased to 3.1Ϯ1.7 at 5-month follow-up (41% improvement) with an absolute increase (⌬CFR) of 0.9Ϯ1.3 (Pϭ0.001).
The mean IMR decreased from 28.7Ϯ10.3 U at early post-AMI phase to 19.1Ϯ6.7 U in long-term follow-up (33.4% improvement) with an absolute decrease (⌬IMR) of 9.6Ϯ10.1 U (PϽ0.001). The improvement in CFR and IMR over the time was primarily attributable to a decrease in hyperemic mean transit time reflecting increase in hyperemic flow (from 0.39Ϯ0.11 at baseline to 0.25Ϯ0.07 at 5 months [PϽ0.001]). The Tmn r reflecting baseline coronary flow did not change significantly over time (0.86Ϯ0.35 at baseline and 0.80Ϯ0.24 at 5 months, Pϭ0.32). The decreases in LVESV (from 49.8Ϯ16.5 mL to 38.5Ϯ11.8 mL, Pϭ0.02) and LVEDV (from 100Ϯ18.9 mL to 88.2Ϯ19.4, Pϭ0.03) from 4 days to long-term follow-up were both significant. The baseline (at 4 days) LVEF was 50.2ϩ6.8%, and it increased to 55.1Ϯ9.2% in the 5-month echocardiography with an absolute increase (⌬LVEF) of 4.9ϩ7.4% (Pϭ0.007; Table 2 ).
The mean values of the relative change in CFR and IMR from 2 days to 5 months were 41% and Ϫ33%, respectively. There were 14 patients with a relative change in IMR of Ͻ33% and 19 patients with a relative change in CFR of Ͻ41%. Significant difference was found with respect to decrease in mean IS from baseline to 5-month follow-up when comparing patients below and above the mean value of the relative change in CFR (Ϫ19Ϯ26.2% versus Ϫ47.2Ϯ 28.2%, Pϭ0.009) and IMR (Ϫ17.2Ϯ22% versus Ϫ40.1Ϯ30.1%, Pϭ0.04) ( Table 3 ). In patients with an improvement in IMR Ͼ33%, the mean IS significantly decreased from 32.3Ϯ16.9% at baseline to 19.3Ϯ14% (Pϭ0.001) at 5 months. But in patients with an improvement in IMR Ͻ33%, the mean IS did not change significantly from baseline to 5-month follow-up (25.5Ϯ12.1% versus 21.1Ϯ11%, Pϭ0. 27) . Similarly, in patients with an improvement in CFR Ͼ41%, the mean IS decreased significantly from 29.9Ϯ20% at baseline to 15.8Ϯ12.4% at 5-month follow-up (Pϭ0.003). Whereas, in patients with an improve- Values are presented as n (%) or meanϮSD. BM indicates below mean; AM, above mean; MVD, multivessel disease; STR, ST resolution; Tmn, mean transit time; CFR, coronary flow reserve; IMR, index of microvascular resistance; IS, infarct size; ACEI, angiotensin-converting enzyme inhibitor. ment in CFR Ͻ41%, relative change in mean IS from baseline to 5-month follow-up was not significant (30.6Ϯ16.5% versus 24.9Ϯ12.05%, Pϭ0.05; Figure 2 ).
In patients with relative change in improvement in CFR was above the mean value of 41%, reduction in LVESV (Ϫ22.3Ϯ16% versus Ϫ4.4Ϯ25.2%, Pϭ0.02) and LVEDV (Ϫ15.5Ϯ19.2% versus Ϫ5.1Ϯ18.8%, Pϭ0.03) was significantly higher, and improvement in LVEF (11.3Ϯ15.4% versus 0.57Ϯ11.3%, Pϭ0.03) was significantly better than in those patients in whom the relative change in CFR was less than the mean value. Similarly, in patients with relative improvement in IMR higher than the mean value of 33%, decrease in LVESV (Ϫ24.4Ϯ14.4% versus Ϫ5.5Ϯ20.1%, Pϭ0.01) and LVEDV (Ϫ16.4Ϯ12.4% versus Ϫ6.5Ϯ17.2%, Pϭ0.02) was significantly higher, and improvement in LVEF (12.8Ϯ13.3% versus 2.5Ϯ10.3%, Pϭ0.02) was significantly better than in those patients with relative change in IMR was below than the mean value ( Table 3) .
The IMR, measured at 2 days after pPCI, was found to be correlated with the fourth day (rϭ0.40, Pϭ0.01) and 5-month IS (rϭ0.44, Pϭ0.007). Furthermore, relationship between early-phase IMR and 5-month IS was still significant even after controlling for early IS (rϭ0.36, Pϭ0.03). Likewise, the CFR, measured at early post-AMI phase, correlated with late-term IS (rϭ0.40, Pϭ0.009), and this correlation was still significant after controlling of early-phase IS (rϭ0.35, Pϭ0.04). But there was no correlation between CFR and early IS.
By multivariate regression, the predictors of the 5-month IS were the baseline values of IS (␤ϭ0.6, PϽ0.001), IMR (␤ϭ0.280, Pϭ0.013), and CFR (␤ϭϪ0.276, Pϭ0.017) ( Table 4 ).
There were significant continuous correlations between relative change in IS and relative changes in measures of microvascular function (CFR% and IS% [rϭϪ0.51, Pϭ0.002]; IMR% and IS% [rϭ0.55; Pϭ0.001]; Figures 3 and 4 ). These correlations remained significant even after controlling of early-phase IS with partial correlation analysis (CFR% and IS% [rϭϪ0.50, Pϭ0.006]; IMR% and IS% [rϭ0.51, Pϭ0.002]). In multivariate regression models, relative change in microvascular perfusion parameters was the only predictor of relative change in IS (change in IMR [␤ϭ0.552, Pϭ0.001] and change in CFR [␤ϭϪ0.511, Pϭ0.002]). Baseline IS was no longer a significant predictor (Pϭ0.10). There were 2 significant outliers as can be seen in Figures 3 and 4 . Removal of these 2 outliers from the analysis did not significantly change the correlation between the relative changes in IMR and IS (rϭ0.55, Pϭ0.001) and the relative changes in CFR and IS (rϭϪ0.58, PϽ0.001).
The relationship between relative changes from 2 days to 5 months in IMR and CFR also was significant (rϭ0.40, Pϭ0.02). There were no correlations between late-term IS and indices of microvascular function measured at 5 months.
Discussion
The results of the present study are 3-fold. First, in patients with STEMI who underwent pPCI with stenting and experienced no events during the 5-month follow-up, the microvas- Below mean: in whom percent change in improvement in CFR or IMR from baseline to 5-month follow-up were below the mean value; above mean: in whom percent change in improvement in CFR or IMR from baseline to 5-month follow-up were above the mean value.
Table 2. Temporal Changes in IS, Indices of Microvascular Perfusion, and LV Volumes and Function From Baseline to 5-Month Follow-Up
cular function in the IRA territory significantly improved. Second, this improvement of microvascular function was proportionally associated with a reduced IS and improved left ventricular function at follow-up. Third, the microvascular function parameters measured early after STEMI independently predicted the IS at follow-up. Taken together, these findings indicate that there is a strong connection between microvascular and infarct remodeling processes after reper- fused STEMI. To our knowledge, this is the first study that has shown that improvement in microvascular function is the single most important predictor of IS evolution in the long term, after reperfused STEMI.
As distinct from previous studies measuring microvascular function, examination of microvascular function and IS measurement by SPECT imaging were both performed 48 hours after reperfusion with the assumption that dynamic changes in resting microvascular perfusion have subsided. 1 Experimental studies have been shown that IS and area of microvascular obstruction increase in the first 48 hours after reperfusion and stabilize at between 2 and 9 days. 1, 15, 16 In accordance with the findings of experimental trails, previous clinical studies examining microvascular function after STEMI also demonstrated that CFR or IMR or both improved at subacute phase (1 to 10 days) as compared with post-pPCI phase. 9, 10, 17, 18 Because of these early dynamic changes, assessment of the microvascular function at 2 days after reperfusion, as was done in the present study, might be more accurate and physiological than measurements immediately after reperfusion.
Temporal changes in CFR and IMR over the time after STEMI have been investigated in few studies in which microvascular function was evaluated immediately after pPCI. 9, 10, 18, 19 In these studies, it has been demonstrated that Doppler-derived CFR and/or microvascular resistance improve progressively during long-term follow-up. 9,10 However, parallel improvements in IS and left ventricular function corresponding to improvement in CFR and IMR during long-term follow-up have not been demonstrated so far. In a recent study, it has been shown that IMR measured immedi-ately after pPCI correlated with peak creatine kinase and predicts recovery of left ventricular function in the short term, whereas CFR did not. 20 Additionally, our study presents the time course of IMR and CFR after reperfusion and their relations with temporal changes in IS and LV function during long-term follow-up. The findings of the current study confirm and expand previous observations that microvascular perfusion in the territory of the IRA improves over a period of 5 months after reperfusion as evidenced by significant improvement in IMR and CFR. Given that resistance of coronary microcirculation (ie, IMR) reflects the total coronary vascular conductance capacity and, thus, cross-sectional area of the coronary vasculature, reduction in IMR can be regarded as reflection of positive microvascular remodeling in the infarcted territory. In the present study, this improvement in microvascular function was translated into a decrease in IS and improvement in left ventricular volumes and function in the long term as well.
In experimental and clinical studies, it has been shown that intracoronary administration of adenosine after reperfusion ameliorates myocardial flow and attenuates functional and structural abnormalities in the microvasculature. [21] [22] [23] The AMI study of adenosine trials confirmed the results of these studies. 24 Although blood flow was not evaluated in the AMI study of adenosine trials, it seems plausible that the beneficial effects (reduction in IS) of adenosine were mediated in part through preservation of tissue perfusion. Likewise, it has been recently reported that administration of intracoronary streptokinase after pPCI in patients with STEMI undergoing pPCI improved microvascular function 7 and this improvement was translated into long-term improvement in left ventricular IS and function. 8 These observations suggest that targeting microvascular perfusion at acute phase of STEMI could enhance long-term left ventricular functional and structural recovery.
In the previous studies, spontaneous IS reduction has been demonstrated at 5 to 7 months after AMI. [25] [26] [27] However, underlying mechanisms for explanation of this infarct healing process, which may facilitate developing new therapies for AMI, were not clearly elucidated. In accord to above- mentioned studies, we demonstrated that decrease in IS by 33% at 5-month follow-up simultaneously occurred with improvement in microvascular function. Significant decrease in IS corresponding to improvement in IMR and CFR in the territory of the IRA occurred especially in patients who developed enhanced positive microvascular remodeling during the follow-up. This finding implies that there may be a bidirectional relationship between microvascular and infarct remodeling processes after reperfused AMI.
Study Limitations
The results of the present study should be considered in the light of some limitations. First, the study population was consisted of selected and relatively small group of patient. However, correlations between measures of microvascular and infarct remodeling processes remained significant despite the size of the study. Additionally, integrity of the coronary microcirculation and IS was carefully assessed using sensitive and quantitative methods at specific time points. Second, in the present study, intracoronary papaverine boluses were used for induction of peak hyperemia. Failure to achieve peak hyperemia, by not achieving maximal reduction in microvascular resistance, may result in overestimation of IMR and underestimation of CFR. In the present study, at the subacute phase and at the follow-up measurements, the recommended dosages of papaverine were used by the same route in all patients. Third, the distance of the pressure wire down a vessel may affect the measured transit times and the IMR. It is of importance to position the sensor at the same location during subsequent measurement. In the present study, the pressure wire was carefully placed as distal as possible in the IRA in all patients and in all measurements, and position of the sensor was recorded by angiography during baseline measurements as a point of reference. At follow-up procedure, we checked baseline angiogram to verify position of pressure sensor and placed the sensor at the position as same as possible. Fourth, measuring IMR and CFR at 2 days post-STEMI is not practical from a clinical standpoint. At last, there were 2 outliers in the data set. Although removing these 2 outliers from the analysis did not significantly change the correlations, this situation should be taken into the consideration.
In conclusion, integrity and functionality of the microcirculation at the territory of the IRA are the main determinant of the evolution of IS. IS reduction is proportional to microvascular functional improvement in the long term. Therefore, making microvascular function better in addition to the reperfusion of the IRA in the acute phase could enhance the left ventricular functional and structural recovery. Because of this connection between microvascular function and IS, future studies should investigate whether therapeutic interventions can protect microvascular function and accordingly improve myocardial healing and function.
